Therefore the goal of this study was to evaluate whether serum level of BNP can be used as a marker for determining the amount of the shunt (Qp/Qs), and the severity of the hemodynamic abnormality in congenital heart diseases with left to right shunt such as VSD, ASD, and PDA.6 The gene discussed is NPPB; the disease is Patent ductus arteriosus.